A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT05252364 · COMPLETED
Trial details
- NCT number
- NCT05252364
- Sponsor
- Hinova Pharmaceuticals Aus Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-14
- Primary completion
- 2024-01-22
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.